Glaukos (GKOS) Cash from Operations (2014 - 2026)
Glaukos' (GKOS) quarterly Cash from Operations came in at 12526000.0 in Q1 2026, up 32.37% year-on-year from 9462964.84 in Q1 2025, and down 283.34% on a QoQ basis from 6832000.0 in Q4 2025.
Glaukos (GKOS) Cash from Operations (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Cash from Operations data on file, last reported at 12526000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 32.37% year-over-year to 12526000.0 in Q1 2026; TTM through Mar 2026 was 8805000.0, a 80.85% increase from a year earlier, with the FY2025 full-year figure at 14800000.0, up 75.86% from the prior year.
- Cash from Operations for Q1 2026 stood at 12526000.0, down from 6832000.0 in the prior quarter.
- Over the last five years, Cash from Operations for GKOS reached as high as 9774000.0 in Q1 2022 and fell as low as 33870000.0 in Q1 2024.
- Historically, Cash from Operations has averaged 10557941.18 across 5 years, with a median of 10090000.0 in 2025.
- Across the five-year window, Cash from Operations slumped 414.75% in 2023 and jumped 1247.53% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 4136000.0 in 2022, then sank by 157.86% to 10665000.0 in 2023, then soared by 104.75% to 507000.0 in 2024, then soared by 1247.53% to 6832000.0 in 2025, then slumped by 283.34% to 12526000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 12526000.0 in Q1 2026, 6832000.0 in Q4 2025, and 10090000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | -12.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.53 Mn |
| Mar 31, 2026 | -12.53 Mn |
| Dec 31, 2025 | 6.83 Mn |
| Dec 31, 2025 | 6.83 Mn |
| Sep 30, 2025 | -10.09 Mn |
| Sep 30, 2025 | -10.09 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | -18.52 Mn |
| Mar 31, 2025 | -18.52 Mn |
| Dec 31, 2024 | 507,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Sep 30, 2024 | -9.59 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Jun 30, 2024 | -18.37 Mn |
| Jun 30, 2024 | -18.37 Mn |
| Mar 31, 2024 | -33.87 Mn |
| Mar 31, 2024 | -33.87 Mn |
| Dec 31, 2023 | -10.67 Mn |
| Dec 31, 2023 | -10.67 Mn |